Differences in serum cytokine levels distinguish between clinically non‐invasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study

Abstract Background Lung cancer incidence and mortality remain high and are now the leading cause of cancer‐related death. Lung adenocarcinoma (LUAD) is one of the main histological subtypes of lung cancer. Previous studies have shown the role of inflammation in the development of lung cancer, but t...

Full description

Bibliographic Details
Main Authors: Bingjie Zeng, Xianzhao Wang, Yueyang Qin, Leiqun Cao, Congcong Zhang, Fanyu Meng, Changqiang Chen, Jiayi Wang, Lifang Ma
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Health Science Reports
Subjects:
Online Access:https://doi.org/10.1002/hsr2.1522
_version_ 1827805777456267264
author Bingjie Zeng
Xianzhao Wang
Yueyang Qin
Leiqun Cao
Congcong Zhang
Fanyu Meng
Changqiang Chen
Jiayi Wang
Lifang Ma
author_facet Bingjie Zeng
Xianzhao Wang
Yueyang Qin
Leiqun Cao
Congcong Zhang
Fanyu Meng
Changqiang Chen
Jiayi Wang
Lifang Ma
author_sort Bingjie Zeng
collection DOAJ
description Abstract Background Lung cancer incidence and mortality remain high and are now the leading cause of cancer‐related death. Lung adenocarcinoma (LUAD) is one of the main histological subtypes of lung cancer. Previous studies have shown the role of inflammation in the development of lung cancer, but the relationship between cytokines and LUAD is still unclear. To further differentiate and explore the association of cytokines with the risk of non‐invasive and invasive LUAD, we studied and assessed serum cytokine levels in patients with two types of LUAD. Methods A cohort study of 90 non‐invasive LUAD and 90 invasive LUAD was retrospectively included, and the clinical characteristics were recorded in detail. The differences in the levels of 12 serum cytokines (IFN‐α, IFN‐γ, IL‐10, IL‐12P70, IL‐17A, IL‐1β, IL‐2, IL‐4, IL‐5, IL‐6, IL‐8, and TNF‐α) between the two groups of patients with LUAD were analyzed and evaluated. And we evaluated the clinical value of cytokine differential diagnosis of invasive LUAD based on receiver operating characteristics (ROC) curves. Results The mean age of the patients was 56.6 years, and the proportions of males and females were 38.9% and 61.1%, respectively. IFN‐α, IL‐1β, IL‐2, IL‐6, TNF‐α, IL‐4, and IL‐8 were significantly increased in patients with invasive LUAD compared with the non‐invasive LUAD group. Further research found that smoking is an important factor, with changes in the four cytokines IL‐1β, IL‐6, IL‐8, and TNF‐α being significantly higher in the smoking group of patients with invasive LUAD. It can be seen from the area under the curve that IL‐1β and IL‐2 have a significant differential diagnosis. Conclusions We observed differences in preoperative serum cytokine levels between patients with invasive and non‐invasive LUAD, which may serve as potential serum biomarkers for clinical differential diagnosis and disease progression assessment.
first_indexed 2024-03-11T21:31:02Z
format Article
id doaj.art-a0b4b47a31f84724a4fcd9a6fe3919d1
institution Directory Open Access Journal
issn 2398-8835
language English
last_indexed 2024-03-11T21:31:02Z
publishDate 2023-09-01
publisher Wiley
record_format Article
series Health Science Reports
spelling doaj.art-a0b4b47a31f84724a4fcd9a6fe3919d12023-09-27T09:16:35ZengWileyHealth Science Reports2398-88352023-09-0169n/an/a10.1002/hsr2.1522Differences in serum cytokine levels distinguish between clinically non‐invasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional studyBingjie Zeng0Xianzhao Wang1Yueyang Qin2Leiqun Cao3Congcong Zhang4Fanyu Meng5Changqiang Chen6Jiayi Wang7Lifang Ma8Department of Laboratory Medicine, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Laboratory Medicine, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Laboratory Medicine, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaShanghai Institute of Thoracic Oncology, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaShanghai Institute of Thoracic Oncology, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaShanghai Institute of Thoracic Oncology, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Laboratory Medicine, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Laboratory Medicine, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Laboratory Medicine, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaAbstract Background Lung cancer incidence and mortality remain high and are now the leading cause of cancer‐related death. Lung adenocarcinoma (LUAD) is one of the main histological subtypes of lung cancer. Previous studies have shown the role of inflammation in the development of lung cancer, but the relationship between cytokines and LUAD is still unclear. To further differentiate and explore the association of cytokines with the risk of non‐invasive and invasive LUAD, we studied and assessed serum cytokine levels in patients with two types of LUAD. Methods A cohort study of 90 non‐invasive LUAD and 90 invasive LUAD was retrospectively included, and the clinical characteristics were recorded in detail. The differences in the levels of 12 serum cytokines (IFN‐α, IFN‐γ, IL‐10, IL‐12P70, IL‐17A, IL‐1β, IL‐2, IL‐4, IL‐5, IL‐6, IL‐8, and TNF‐α) between the two groups of patients with LUAD were analyzed and evaluated. And we evaluated the clinical value of cytokine differential diagnosis of invasive LUAD based on receiver operating characteristics (ROC) curves. Results The mean age of the patients was 56.6 years, and the proportions of males and females were 38.9% and 61.1%, respectively. IFN‐α, IL‐1β, IL‐2, IL‐6, TNF‐α, IL‐4, and IL‐8 were significantly increased in patients with invasive LUAD compared with the non‐invasive LUAD group. Further research found that smoking is an important factor, with changes in the four cytokines IL‐1β, IL‐6, IL‐8, and TNF‐α being significantly higher in the smoking group of patients with invasive LUAD. It can be seen from the area under the curve that IL‐1β and IL‐2 have a significant differential diagnosis. Conclusions We observed differences in preoperative serum cytokine levels between patients with invasive and non‐invasive LUAD, which may serve as potential serum biomarkers for clinical differential diagnosis and disease progression assessment.https://doi.org/10.1002/hsr2.1522cytokineinflammationinvasive lung adenocarcinomanon‐invasive lung adenocarcinoma
spellingShingle Bingjie Zeng
Xianzhao Wang
Yueyang Qin
Leiqun Cao
Congcong Zhang
Fanyu Meng
Changqiang Chen
Jiayi Wang
Lifang Ma
Differences in serum cytokine levels distinguish between clinically non‐invasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study
Health Science Reports
cytokine
inflammation
invasive lung adenocarcinoma
non‐invasive lung adenocarcinoma
title Differences in serum cytokine levels distinguish between clinically non‐invasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study
title_full Differences in serum cytokine levels distinguish between clinically non‐invasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study
title_fullStr Differences in serum cytokine levels distinguish between clinically non‐invasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study
title_full_unstemmed Differences in serum cytokine levels distinguish between clinically non‐invasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study
title_short Differences in serum cytokine levels distinguish between clinically non‐invasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study
title_sort differences in serum cytokine levels distinguish between clinically non invasive lung adenocarcinoma and invasive lung adenocarcinoma a cross sectional study
topic cytokine
inflammation
invasive lung adenocarcinoma
non‐invasive lung adenocarcinoma
url https://doi.org/10.1002/hsr2.1522
work_keys_str_mv AT bingjiezeng differencesinserumcytokinelevelsdistinguishbetweenclinicallynoninvasivelungadenocarcinomaandinvasivelungadenocarcinomaacrosssectionalstudy
AT xianzhaowang differencesinserumcytokinelevelsdistinguishbetweenclinicallynoninvasivelungadenocarcinomaandinvasivelungadenocarcinomaacrosssectionalstudy
AT yueyangqin differencesinserumcytokinelevelsdistinguishbetweenclinicallynoninvasivelungadenocarcinomaandinvasivelungadenocarcinomaacrosssectionalstudy
AT leiquncao differencesinserumcytokinelevelsdistinguishbetweenclinicallynoninvasivelungadenocarcinomaandinvasivelungadenocarcinomaacrosssectionalstudy
AT congcongzhang differencesinserumcytokinelevelsdistinguishbetweenclinicallynoninvasivelungadenocarcinomaandinvasivelungadenocarcinomaacrosssectionalstudy
AT fanyumeng differencesinserumcytokinelevelsdistinguishbetweenclinicallynoninvasivelungadenocarcinomaandinvasivelungadenocarcinomaacrosssectionalstudy
AT changqiangchen differencesinserumcytokinelevelsdistinguishbetweenclinicallynoninvasivelungadenocarcinomaandinvasivelungadenocarcinomaacrosssectionalstudy
AT jiayiwang differencesinserumcytokinelevelsdistinguishbetweenclinicallynoninvasivelungadenocarcinomaandinvasivelungadenocarcinomaacrosssectionalstudy
AT lifangma differencesinserumcytokinelevelsdistinguishbetweenclinicallynoninvasivelungadenocarcinomaandinvasivelungadenocarcinomaacrosssectionalstudy